The article discusses hepatotoxicity, primarily induced by high-fat diets (HFDs), which can lead to conditions like non-alcoholic fatty liver disease (NAFLD) and dyslipidemia. Obesity, often stemming from unhealthy eating, is a global health issue …
The article discusses the rising prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), affecting around 400 million people in China, and emphasizes the urgent need for innovative treatments. Lipoic acid (LA), an antioxidant …
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a chronic liver condition marked by excessive fat accumulation in the liver without significant alcohol consumption, affecting around 30% of adults globally. Key risk factors include …
Fat embolism syndrome (FES) is primarily linked to orthopedic injuries, especially long-bone fractures, but is increasingly noted in organ transplant patients. Since the first case reported in 1965, its incidence in transplant recipients is estimated …
Nonalcoholic fatty liver disease (NAFLD) is a condition marked by excess fat accumulation in the liver, affecting over one-third of adults globally, often linked to obesity and Type 2 diabetes. NAFLD can progress to more severe forms like …
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), involves fat accumulation in the liver unrelated to significant alcohol intake. This condition is increasingly prevalent …
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a newly adopted term that encompasses various liver conditions linked to metabolic dysfunction, previously referred to as Non-Alcoholic Fatty Liver Disease (NAFLD). This shift aims …
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) is now the most common chronic liver disease worldwide, with approximately 1.27 billion cases reported in 2021. Its rise is linked to the global obesity epidemic, metabolic syndrome, and …
The article discusses the benefits of silymarin, a natural extract from milk thistle, in treating chronic liver disease (CLD). Key studies show silymarin’s effectiveness in improving liver function and lipid profiles, particularly in patients …
Fatty liver disease is characterized by excess fat accumulation in liver cells, often linked to obesity, insulin resistance, type 2 diabetes, and metabolic syndrome. It can escalate to more severe conditions such as MASH, leading to liver …
Fatty liver disease, or steatosis, is the accumulation of excess fat in liver cells, affecting about one in ten people, particularly in Western countries. It can lead to serious complications such as steatohepatitis, cirrhosis, and liver failure. The …
Fatty liver disease, or hepatic steatosis, involves excess fat accumulation in liver cells and is primarily divided into alcoholic fatty liver disease (AFLD) and non-alcoholic fatty liver disease (NAFLD). NAFLD affects about 25% of the global …
The article discusses fatty liver disease, now known as metabolic dysfunction-associated steatotic liver disease (MASLD), which is characterized by fat accumulation in liver cells due to factors like obesity and insulin resistance. Often …
Fatty liver disease, now known as metabolic dysfunction-associated steatotic liver disease (MASLD), involves excess fat accumulation in liver cells and is linked to metabolic dysfunction rather than alcohol use. It can progress through stages, …
Elevated liver enzymes indicate liver cell damage or inflammation and are commonly detected through routine blood tests. The primary enzymes measured include ALT, AST, ALP, and GGT. While elevated levels are often temporary and resolve without …
Nonalcoholic steatohepatitis (NASH) is a progressive liver disease marked by fat accumulation, inflammation, and liver cell damage, potentially leading to serious conditions like cirrhosis and liver cancer. Its prevalence is increasing, particularly …
